沙特重症医学会成人创伤静脉血栓栓塞预防临床实践指南:经证据基础完整性审查并获斯堪的纳维亚麻醉学与重症医学会认可
沙特重症医学会(SCCS)组织22名多学科专家制定成人创伤住院患者静脉血栓栓塞(VTE)预防指南,采用GRADE方法评价证据并用EtD框架形成推荐。共发布12条推荐:1条强推荐、10条弱推荐、1条因证据不足未作推荐。推荐涉及非手术钝性实质性脏器损伤、孤立性钝性颅脑损伤、孤立性钝性脊柱创伤/骨折和/或脊髓损伤的早期药物预防启动时机,药物选择与剂量、机械预防、常规双功超声筛查及下腔静脉滤器。强推荐为不能药物预防的创伤成人使用间歇性充气加压(IPC)机械预防;建议反对常规放置预防性下腔静脉滤器。
要点
- 对不能进行药物VTE预防的创伤成人,SCCS强烈推荐使用间歇性充气加压(IPC)机械预防。
- 对非手术钝性实质性脏器损伤、孤立性钝性颅脑损伤和脊髓损伤,SCCS建议早期启动药物VTE预防。
- 药物预防选择上,SCCS建议低分子肝素(LMWH)优于普通肝素(UFH)。
- SCCS建议使用中等-高剂量LMWH或常规剂量LMWH(两者均可)。
- SCCS建议对VTE风险升高且不适合药物预防的创伤成人行常规双下肢超声,并建议反对常规放置预防性下腔静脉滤器。
适用人群与场景
- 成人创伤住院患者(住院场景)。
- 涉及亚组:非手术钝性实质性脏器损伤、孤立性钝性颅脑损伤(TBI)、孤立性钝性脊柱创伤或骨折和/或脊髓损伤(SCI)、不适合药物预防者、VTE风险升高且不适合药物预防者、需要神经外科手术的孤立性钝性TBI。
处置流程与药物剂量
- 对非手术钝性实质性脏器损伤、孤立性钝性TBI和SCI,建议早期启动药物VTE预防(弱推荐)。
- 药物VTE预防建议使用低分子肝素(LMWH)而非普通肝素(UFH)(弱推荐)。
- 药物VTE预防建议使用中等-高剂量LMWH或常规剂量LMWH(弱推荐)。
- 对不是药物预防候选者的创伤成人,强烈推荐使用间歇性充气加压(IPC)机械VTE预防。
- 建议使用机械联合药物VTE预防或单用药物VTE预防(弱推荐)。
- 对VTE风险升高且不适合药物VTE预防的创伤成人,建议常规双下肢超声(弱推荐)。
- 建议反对常规放置预防性下腔静脉滤器(IVCF)(弱推荐)。
- 对需要神经外科手术的孤立性钝性TBI成人,因证据不足未作早期药物VTE预防推荐。
研究设计与关键结果
- SCCS赞助制定指南,纳入22名多学科专家组成员并完成利益冲突申报。
- 共发布12条临床实践推荐:1条强推荐、10条弱推荐、1条因证据不足未作推荐。
- 优先领域包括:非手术钝性实质性脏器损伤、孤立性钝性TBI、孤立性钝性脊柱创伤或骨折和/或SCI的药物VTE预防启动时机;药物VTE预防类型与剂量;机械VTE预防;常规双功超声监测;下腔静脉滤器。
证据类型、等级与局限
- 证据类型:临床实践指南;采用GRADE方法评价证据质量,并使用EtD框架形成推荐。
- 推荐强度构成:1条强推荐、10条弱推荐、1条因证据不足未作推荐。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对无药物预防指征的创伤成人,床旁应落实IPC机械预防(SCCS强烈推荐)。
- 药物预防可选LMWH而非UFH,并可选择中等-高剂量或常规剂量LMWH(SCCS弱推荐)。
- 对VTE风险升高且不适合药物预防者,可行常规双下肢超声筛查(SCCS弱推荐)。
- 不应常规放置预防性下腔静脉滤器(SCCS弱推荐反对)。
- 需要神经外科手术的孤立性钝性TBI成人早期药物预防尚无推荐,原文未据此给出推荐。
指南或共识出处
- 沙特重症医学会(SCCS)成人创伤静脉血栓栓塞预防临床实践指南,发表于Ann Intensive Care,经证据基础完整性审查并获斯堪的纳维亚麻醉学与重症医学会认可。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: To develop evidence-based clinical practice guidelines on venous thromboembolism (VTE) prevention in adults with trauma in inpatient settings.
METHODS: The Saudi Critical Care Society (SCCS) sponsored guidelines development and included 22 multidisciplinary panel members who completed conflict-of-interest forms. The panel developed and answered structured guidelines questions. For each question, the literature was searched for relevant studies. To summarize treatment effects, meta-analyses were conducted or updated. Quality of evidence was assessed using the Grading Recommendations, Assessment, Development, and Evaluation (GRADE) approach, then the evidence-to-decision (EtD) framework was used to generate recommendations. Recommendations covered the following prioritized domains: timing of pharmacologic VTE prophylaxis initiation in non-operative blunt solid organ injuries; isolated blunt traumatic brain injury (TBI); isolated blunt spine trauma or fracture and/or spinal cord injury (SCI); type and dose of pharmacologic VTE prophylaxis; mechanical VTE prophylaxis; routine duplex ultrasonography (US) surveillance; and inferior vena cava filters (IVCFs).
RESULTS: The panel issued 12 clinical practice recommendations-one, a strong recommendation, 10 weak, and one with no recommendation due to insufficient evidence. The panel suggests starting early pharmacologic VTE prophylaxis for non-operative blunt solid organ injuries, isolated blunt TBIs, and SCIs. The panel suggests using low molecular weight heparin (LMWH) over unfractionated heparin (UFH) and suggests either intermediate-high dose LMWH or conventional dosing LMWH. For adults with trauma who are not pharmacologic candidates, the panel strongly recommends using mechanical VTE prophylaxis with intermittent pneumatic compression (IPC). The panel suggests using either combined VTE prophylaxis with mechanical and pharmacologic methods or pharmacologic VTE prophylaxis alone. Additionally, the panel suggests routine bilateral lower extremity US in adults with trauma with elevated risk of VTE who are ineligible for pharmacologic VTE prophylaxis and suggests against the routine placement of prophylactic IVCFs. Because of insufficient evidence, the panel did not issue any recommendation on the use of early pharmacologic VTE prophylaxis in adults with isolated blunt TBI requiring neurosurgical intervention.
CONCLUSION: The SCCS guidelines for VTE prevention in adults with trauma were based on the best available evidence and identified areas for further research. The framework may facilitate adaptation of recommendations by national/international guideline policymakers.
参考来源
- Amer M, Alshahrani MS, Arabi YM, et al. Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Ann Intensive Care. 2023. PMID: 37165105. doi:10.1186/s13613-023-01135-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。